Wang Ke - Net Worth and Insider Trading

Wang Ke Net Worth

The estimated net worth of Wang Ke is at least $0 dollars as of 2024-11-08. Wang Ke is the Directors, executives of Changzhou Qianhong Biopharma Co Ltd and owns about 0 shares of Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) stock worth over $0. Details can be seen in Wang Ke's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wang Ke has not made any transactions after 2022-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Wang Ke

To

Wang Ke Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wang Ke owns 1 companies in total, including Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) .

Click here to see the complete history of Wang Ke’s form 4 insider trades.

Insider Ownership Summary of Wang Ke

Ticker Comapny Transaction Date Type of Owner
SZSE:002550 Changzhou Qianhong Biopharma Co Ltd 2022-06-30 Directors & executives

Wang Ke Latest Holdings Summary

Wang Ke currently owns a total of 1 stock. Wang Ke owns 0 shares of Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) as of June 30, 2022, with a value of $0.

Latest Holdings of Wang Ke

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:002550 Changzhou Qianhong Biopharma Co Ltd 2022-06-30 0 6.55 0

Holding Weightings of Wang Ke


Wang Ke Form 4 Trading Tracker

According to the SEC Form 4 filings, Wang Ke has made a total of 3 transactions in Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Changzhou Qianhong Biopharma Co Ltd is the acquisition of 4,200,000 shares on June 30, 2022, which cost Wang Ke around $21 Million.

Insider Trading History of Wang Ke

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wang Ke Trading Performance

GuruFocus tracks the stock performance after each of Wang Ke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wang Ke is -7.56%. GuruFocus also compares Wang Ke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wang Ke within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Wang Ke's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Wang Ke

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.13 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Wang Ke Ownership Network

Ownership Network List of Wang Ke

No Data

Ownership Network Relation of Wang Ke

Insider Network Chart

Wang Ke Owned Company Details

What does Changzhou Qianhong Biopharma Co Ltd do?

Who are the key executives at Changzhou Qianhong Biopharma Co Ltd?

Wang Ke is the Directors & executives of Changzhou Qianhong Biopharma Co Ltd. Other key executives at Changzhou Qianhong Biopharma Co Ltd include Executives huang jie , Supervisors Jiang Wen Qun , and Executives Zou Shao Bo .

Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) Insider Trades Summary

Over the past 18 months, Wang Ke made no insider transaction in Changzhou Qianhong Biopharma Co Ltd (SZSE:002550). Other recent insider transactions involving Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) include a net purchase of 700 shares made by huang jie ,

In summary, during the past 3 months, insiders sold 0 shares of Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) in total and bought 700 shares, with a net purchase of 700 shares. During the past 18 months, 0 shares of Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) were sold and 700 shares were bought by its insiders, resulting in a net purchase of 700 shares.

Changzhou Qianhong Biopharma Co Ltd (SZSE:002550)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Changzhou Qianhong Biopharma Co Ltd Insider Transactions

No Available Data

Wang Ke Mailing Address

Above is the net worth, insider trading, and ownership report for Wang Ke. Currently GuruFocus does not have mailing address information for Wang Ke.